> Details

Wimberger, Pauline; Bachmann, Hagen Sjard; Du Bois, Andreas; Kimmig, Rainer; Kuhlmann, Jan Dominik; Siffert, Winfried; Sehouli, Jalid; Wollschlaeger, Kerstin; Huober, Jens Bodo; Hillemanns, Peter; Burges, Alexander; Schmalfeldt, Barbara; Aminossadati, Behnaz; Meier, Werner

The FNTB-609GC polymorphism as a possible predictive factor for efficacy of lonafarnib-treatment? Exploratory analysis of a randomized phase II clinical trial in stage IIb-IV ovarian cancer, treated with first-line platinum-based chemotherapy with or without lonafarnib

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: The FNTB-609GC polymorphism as a possible predictive factor for efficacy of lonafarnib-treatment? Exploratory analysis of a randomized phase II clinical trial in stage IIb-IV ovarian cancer, treated with first-line platinum-based chemotherapy with or without lonafarnib
  • Contributor: Wimberger, Pauline; Bachmann, Hagen Sjard; Du Bois, Andreas; Kimmig, Rainer; Kuhlmann, Jan Dominik; Siffert, Winfried; Sehouli, Jalid; Wollschlaeger, Kerstin; Huober, Jens Bodo; Hillemanns, Peter; Burges, Alexander; Schmalfeldt, Barbara; Aminossadati, Behnaz; Meier, Werner
  • imprint: American Society of Clinical Oncology (ASCO), 2014
  • Published in: Journal of Clinical Oncology
  • Language: English
  • DOI: 10.1200/jco.2014.32.15_suppl.e16534
  • ISSN: 0732-183X; 1527-7755
  • Keywords: Cancer Research ; Oncology
  • Origination:
  • Footnote:
  • Access State: Open Access